Wu Hui-Lan
Known title: Chief Financial OfficerCIK: 0001901988
Associated companies
Transaction History
| AIMD | ▲ Buy | Grant | 5,250 | $6K | 6/30/2023 | View on chart |
| AIMD | ▲ Buy | Grant | 133,333 | $252K | 10/24/2022 | View on chart |
| AIMD | ▲ Buy | Grant | 14,705 | $50K | 8/9/2022 | View on chart |
| AIMD | ▲ Buy | Grant | 14,705 | $50K | 8/9/2022 | View on chart |
| AIMD | ▲ Buy | Grant | 168,000 | $84K | 12/20/2021 | View on chart |
| AIMD | ▲ Buy | Grant | 63,000 | $32K | 12/20/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 2, 2026
Ainos Completes VELDONA Transfer and ASE Delivery
Ainos Inc. has completed the technology transfer for its VELDONA project, triggering a $600,000 license payment. The company also finished delivering 1,400 AI Nose systems to ASE under a three-year contract valued at $2.1 million. These developments highlight Ainos' focus on chemical intelligence and partner-funded development.
Ainos Completes VELDONA Transfer and ASE Delivery. Ainos Inc. has completed the technology transfer for its VELDONA project, triggering a $600,000 license payment. The company also finished delivering 1,400 AI Nose systems to ASE under a three-year contract valued at $2.1 million. These developments highlight Ainos' focus on chemical intelligence and partner-funded development.